SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as the community reacts to record-breaking revenue growth and strong U.S. commercial adoption, even as market participants debate whether these results justify its high valuation. Discussions remain polarized, with many investors citing the companys accelerating momentum as a long-term catalyst while others point to significant price action stagnation as evidence of market manipulation and lingering valuation concerns.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as investors digest a second round of layoffs targeting the technology division, while community discussion remains sharply divided between those calling the stock a generational value play due to insider buying and those betting on further downside amidst persistent brand struggles.

SKK Holdings Ltd. operates as a holding company, which engages in the provision of civil engineering services in subsurface utility works, including power and telecommunication cable laying, water pipeline and sewer rehabilitation works. The company was founded by Chun Seong Ng and Koon Kiat Sze on October 16, 2013 and is headquartered in Singapore.

SKK Holdings Ltd. - Ordinary Shares - Class A

SKK Holdings Ltd

SKK Holdings is experiencing extreme volatility following a significant drone asset acquisition agreement, driving intense community debate over its low-float momentum versus potential long-term dilution risks. Traders are actively discussing the stock's parabolic gains and the resulting struggle between aggressive bulls targeting higher price levels and bears anticipating a sharp reversal.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is seeing intense investor debate as the market re-evaluates the stock following earnings, with many users focused on the company's strategic pivot toward prioritizing long-term user engagement over immediate monetization. While some community members view the resulting price volatility as a potential generational buying opportunity, others express deep skepticism regarding the firm's competitive moat in the age of generative AI.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARB IOT Group Ltd is generating significant buzz on social media as traders bet on a potential short squeeze, citing its extremely low float as a primary catalyst for rapid price movement. Community members are actively sharing aggressive price targets and comparing the stock to other recent high-volatility runners, though others remain cautious, warning of potential pump-and-dump activity due to high volatility and thin liquidity.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is currently experiencing significant market volatility after announcing an aggressive plan to reduce its daily package volume from Amazon, a strategic shift that has left the community divided between those optimistic about margin expansion and others concerned about long-term growth. Investors are closely monitoring the company's workforce reduction efforts and cost-cutting initiatives as they weigh the stock's high dividend yield against risks in a margin-sensitive logistics industry.

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Cns Pharmaceuticals Inc

Cns Pharmaceuticals is seeing intense volatility and retail activity driven by the announcement of a multi-million dollar private placement financing. The community is actively debating whether this news acts as a legitimate validation of the company's pipeline or as further dilutive pressure, with traders closely monitoring the stock's low float for potential squeeze momentum.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is drawing intense investor attention as its strong Q1 earnings, highlighted by a significant double beat and doubled AI data center revenue, fuel a fierce debate between long-term bulls betting on its recovery and bears arguing the stock is overextended and tied to slowing industrial markets. The community is heavily focused on whether the firm's guidance and margin outlook can justify its recent price run-up or if the current momentum is merely a short-term reaction to sector-wide sentiment.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is currently trending as the community debates its future performance, with investors divided between bullish expectations for a potential ETF filing and skepticism regarding its status as a meme coin. Sentiment is heavily focused on historical price comparisons and the coin's ability to maintain upward momentum alongside broader crypto market movements.

Mask Network is the core product of Dimension, which is positioned to become the bridge that connects internet users from Web 2.0 to Web 3.0. The foundational technology of Mask Network is a peer-to-peer encrypted messaging application, with new functions continuously being created around this foundation. We at Mask Network are strong believers in the ownership economy. People should own what they produce, people should own their data, their attention and the virtual space they choose to contribute to.  Mask Network integrates decentralized social messaging, borderless payment network, and decentralized file storage and sharing to provide a safe and convenient portal for users to jump right into the continent of decentralized finance and then the new world of Web 3.0.

Mask Network

Mask Network is trending due to a fresh $1.3 million institutional convertible note deal, which investors see as a fundamental catalyst for its ongoing AI infrastructure expansion. The community is actively debating the stock's potential to rally as it attempts to break through critical price resistance levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GeneDx Q1 Earnings Call Highlights

GeneDx (NASDAQ:WGS) reported first-quarter 2026 results showing continued growth in exome and genome testing volumes, but lower-than-expected revenue as a shift in product mix pressured reimbursement rates and several non-core business lines underperformed.

Q1 results: Volume up 34% as revenue miss...

<ul class="summary-bullets"><li>It also lowered expected exome and genome revenue growth to at least 20%, from 33–35%, while maintaining volume growth of at least 30%.</li><li>Stueland added that the company remains confident in its long-term strategy after “resetting expectations.”</li><li>GeneDx posted first-quarter revenue of $102.3 million, up 17% from $87.1 million a year earlier, but below an analyst estimate of $112.45 million. &nbsp;</li></ul>GeneDx Holdings Corp. (WGS) shares tumbled roughly 40% in after-hours trading on Monday after the company reported first-quarter results below Wall Street estimates and sharply lowered its full-year 2026 revenue outlook, citing slower-than-expected market dynamics.GeneDx posted first-quarter revenue of $102.3 million, up 17% from $87.1 million a year earlier, but below an analyst estimate of $112.45 million. Exome and genome testing revenue — the company’s flagship offering — climbed 27% to $90.6 million on 34% higher test volume.Adjusted loss per share came in at $0.28, compared to earnings per share of $0.31 in the corresponding quarter of 2025, and more than an estimates loss of $0.02 per share. &nbsp;<h2 class="st-heading-2">2026 Guidance</h2>GeneDx also cut its full-year 2026 revenue guidance to $475–$490 million, well below its prior range of $540–$555 million. It also lowered expected exome and genome revenue growth to at least 20%, from 33–35%, while maintaining volume growth of at least 30% and adjusted gross margin of approximately 70%. For the second quarter, the company guided revenue to $110–$112 million with roughly 30,000 exome and genome tests.“GeneDx delivered 34% year-over-year volume growth in exome and genome testing in the first quarter — a clear signal that there’s sustained, strong demand for our services,” said CEO Katherine Stueland. “While our revenue did not reflect the full potential of what this business is capable of, we are adjusting our outlook and are poised to deliver more than 30% volume growth, 70% gross margin, and profitability on an adjusted basis for the year.”Stueland added that the company remains confident in its long-term strategy after “resetting expectations.”GeneDx ended the quarter with $171.7 million in cash, cash equivalents, marketable securities, and restricted cash.<h2 class="st-heading-2">How Did WGS Retail Traders React?</h2>On Stocktwits, retail sentiment around WGS jumped from bearish to extremely bullish territory over the past 24 hours, while message volume rose from normal to extremely high levels.A Stocktwits user expressed optimism for the stock stabilizing on Tuesday.<stembedurl>https://www.stocktwits.com/Birddog42/message/652244744</stembedurl>Another dismissed the stock as oversold.<stembedurl>https://www.stocktwits.com/bc4/message/652244546</stembedurl>A third user highlighted the company’s low cash reserve.<stembedurl>https://www.stocktwits.com/v92/message/652239884</stembedurl><a href="https://stocktwits.com/symbol/WGS">WGS stock</a> gained 3% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/ford-warns-of-no-fair-fight-with-chinese-evs-while-byd-dwarfs-its-april-output/cZQu5XdReJq">Ford Warns Of ‘No Fair Fight’ With Chinese EVs While BYD Dwarfs Its April Output</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of GeneDx Holdings Corp, a U.S.-based genomic testing company. (Photo illustration by Cheng Xin/Getty Images)

WGS Stock Slumps After Hours As Firm Predicts Lower Test Volume For Year

GeneDx cut its full-year 2026 revenue guidance to $475–$490 million, well below its prior range of $540–$555 million.

Equity

GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Lags Revenue Estimates

GENEDX HOLDINGS (WGS) delivered earnings and revenue surprises of -366.67% and -7.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook

GeneDx Holdings Corp. (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today reported its financial results for the first quarter of 2026...

Jennison Associates LLC Has $39.30 Million Position in GeneDx Holdings Corp. $WGS

Jennison Associates LLC lowered its stake in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 49.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 302,149 shares of the company's s...

GeneDx (NASDAQ:WGS) CFO Kevin Feeley Sells 392 Shares

GeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CFO Kevin Feeley sold 392 shares of the company's stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $65.19, for a total value of $25,554.48. Following the sale, the chief financial officer owned 34,942...

GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 2,172 Shares

GeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 2,172 shares of GeneDx stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $65.19, for a total value of $141,592.68. Following the sale, the chief executive officer...

Will Robust Exome and Genome Revenues Lift GeneDx's Q1 Earnings? 

GeneDx heads into Q1 earnings results with strong exome and genome momentum, supported by expanding adoption and a growing rare-disease data advantage.

GeneDx (WGS) Projected to Post Quarterly Earnings on Monday

GeneDx (NASDAQ:WGS) will be releasing its Q1 2026 earnings before the market opens on Monday, May 4. (View Earnings Report at...

Peregrine Capital Management LLC Reduces Stock Holdings in GeneDx Holdings Corp. $WGS

Peregrine Capital Management LLC decreased its position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 27.2% during the 4th quarter, according to the company in its most recent disclosure...

$WGS Q1 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$2.16 down -839.13% YoY
• Reported revenue of $102.25M up 17.38% YoY
• GeneDx updated its full-year 2026 revenue guidance to $475M to $490M, a reduction from previous guidance, while maintaining expectations for at least 30% exome and genome volume growth.

Stocktwits

GeneDx Holdings Corp

 Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$2.16 down -839.13% YoY
• Reported revenue of $102.25M up 17.38% YoY
• GeneDx updated its full-year 2026 revenue guidance to $475M to $490M, a reduction from previous guidance, while maintaining expectations for at least 30% exome and genome volume growth.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Holdings Corp - Ordinary Shares - Class A

Continue higher

Sideways action

Retreat lower

What’s your read on the market for next week?

Stocktwits Polls

Investors are reacting to a massive guidance cut and revenue miss that sent the stock plunging over 40% after hours.

Traders are debating whether the sharp price drop provides a long-term entry point or if the business outlook remains too broken to buy.

WGS
GeneDx Holdings Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest WGS News

WGSGeneDx Holdings Corp